Holdings
Kalehua Capital Management LLC
As of Jun 30, 2026, Kalehua Capital Management LLC reported 19 positions worth US$220M. Largest: Veradermics, Incorporated, X4 Pharmaceuticals, Inc. and Surrozen, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Veradermics, Incorporated | 291K | US$35.8M | +42,816 | Jun 30, 2026 |
| X4 Pharmaceuticals, Inc. | 7.45M | US$34.8M | no change | Jun 30, 2026 |
| Surrozen, Inc. | 770K | US$20M | no change | Jun 30, 2026 |
| Aclaris Therapeutics, Inc. | 3.66M | US$19.4M | +495K | Jun 30, 2026 |
| Sionna Therapeutics, Inc. | 394K | US$17.3M | no change | Jun 30, 2026 |
| Inhibikase Therapeutics, Inc. | 7.64M | US$15.5M | +1.15M | Jun 30, 2026 |
| Karyopharm Therapeutics Inc. | 1.37M | US$13.4M | new | Jun 30, 2026 |
| Septerna, Inc. | 389K | US$13M | no change | Jun 30, 2026 |
| Cyclerion Therapeutics, Inc. | 3.3M | US$11.2M | new | Jun 30, 2026 |
| Leonabio, Inc. | 787K | US$7.24M | no change | Jun 30, 2026 |